Skip to content

Drug interactions

Indacaterol-glycopyrronium + Nebivolol

Severity: Moderate

Indacaterol-glycopyrronium and Nebivolol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nebivolol is a highly cardioselective beta-blocker, but it can still blunt indacaterol's effect and cause bronchospasm at higher doses. The risk is lower than with nonselective agents.

What this interaction means in plain words

Indacaterol-glycopyrronium and Nebivolol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Indacaterol-glycopyrronium belongs to Respiratory; Nebivolol belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Beta-receptor antagonism opposing beta-2 agonist bronchodilation, with selectivity lost at higher doses.

What to do

Use the lowest effective nebivolol dose and monitor respiratory symptoms and lung function. Reassess if bronchospasm or reduced bronchodilator response occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Nebivolol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Nebivolol?

MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Nebivolol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nebivolol is a highly cardioselective beta-blocker, but it can still blunt indacaterol's effect and cause bronchospasm at higher doses. The risk is lower than with nonselective agents.

How serious is the interaction between Indacaterol-glycopyrronium and Nebivolol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the lowest effective nebivolol dose and monitor respiratory symptoms and lung function. Reassess if bronchospasm or reduced bronchodilator response occurs.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in